glp-1 agonist. A Closer Look at the Dermatological Profile of Agonists GLP-1 Receptor Agonists and Research
Description
Despite variations in data sources, adjustment techniques, risk estimates, and comparator drugs, these findings collectively suggest that GLP-1RAs are not associated with an altered risk of depression
Furthermore, concerning the application segment, the market is segregated into type 2 diabetes mellitus, obesity, and others
On a broader societal level, the use of GLP-1 medications for weight loss may be reinforcing the negative stigmas around fatness and being overweight that often contribute to the development of eating disorders
95% CI, 0.53-0.87)
Twenty years ago, Lilly helped launch the first approved GLP-1 drug
